InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

- Current share price for MVP : $0.490

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$55 Change in substantial holding 17 Aug 2022 2:00PM $1.960 $0.490 fallen by 75%
$55 Becoming a substantial holder 15 Aug 2022 3:19PM $2.000 $0.490 fallen by 75.50%
$55 Appendix 2A Application for quotation of securities 12 Aug 2022 10:57AM $1.960 $0.490 fallen by 75%
$55 Dispatch of Prospectus 11 Aug 2022 4:55PM $2.000 $0.490 fallen by 75.50%
$55 Entitlement Offer Notification to Ineligible Shareholders 11 Aug 2022 3:20PM $1.990 $0.490 fallen by 75.38%
$55 Completion of Placement and Institutional Entitlement Offer 8 Aug 2022 9:07AM $2.400 $0.490 fallen by 79.58%
$55 Update - Proposed issue of securities - MVP 4 Aug 2022 12:14PM $2.400 $0.490 fallen by 79.58%
$55 Proposed issue of securities - MVP 4 Aug 2022 9:42AM $2.400 $0.490 fallen by 79.58%
$55 Prospectus - Entitlement Offer and Options 4 Aug 2022 9:35AM $2.400 $0.490 fallen by 79.58%
$55 Investor Presentation - $30m Capital Raise and FY22 Guidance 4 Aug 2022 9:31AM $2.400 $0.490 fallen by 79.58%
$55 MVP Announces $30m Capital Raise and FY22 Guidance 4 Aug 2022 9:27AM $2.400 $0.490 fallen by 79.58%
$55 Trading Halt 4 Aug 2022 8:44AM $2.400 $0.490 fallen by 79.58%
$55 Appointment of General Counsel and Company Secretary 30 May 2022 12:12PM $2.610 $0.490 fallen by 81.23%
$55 Notification of cessation of securities - MVP 26 May 2022 10:51AM $2.530 $0.490 fallen by 80.63%
$55 MVP signs new Penthrox licensing agreement in Canada 10 May 2022 3:35PM $3.040 $0.490 fallen by 83.88%
$55 Notification of cessation of securities - MVP 5 May 2022 4:59PM $3.310 $0.490 fallen by 85.20%
$55 Chief Financial Officer Transition 5 May 2022 12:13PM $3.400 $0.490 fallen by 85.59%
$55 Appendix 2A 3 May 2022 2:49PM $3.480 $0.490 fallen by 85.92%
$55 Notification regarding unquoted securities - MVP 2 May 2022 4:37PM $3.510 $0.490 fallen by 86.04%
$55 Notification regarding unquoted securities - MVP 2 May 2022 4:30PM $3.510 $0.490 fallen by 86.04%
$55 Notification regarding unquoted securities - MVP 2 May 2022 4:24PM $3.510 $0.490 fallen by 86.04%
$55 Notification regarding unquoted securities - MVP 2 May 2022 4:11PM $3.510 $0.490 fallen by 86.04%
$55 Proposed issue of securities - MVP 2 May 2022 2:26PM $3.485 $0.490 fallen by 85.94%
$55 US FDA Investor Presentation 3 Mar 2022 8:37AM $4.490 $0.490 fallen by 89.09%
$55 Green Whistle gets the Green Light - FDA Clears US Trial 2 Mar 2022 10:18AM $3.410 $0.490 fallen by 85.63%

176 - 200 of 616 results

Page 8 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.